Apex Biotechnology Corp.

TWSE:1733.TW

30.35 (TWD) • At close June 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

2024202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 153.127140.962199.575184.936110.615162.94161.345111.97452.086311.293318.942426.379522.446526.617453.949326.483
Depreciation & Amortization 64.8175.7194.195.675105.198116.199105.892109.742103.218112.097114.84397.50988.73684.02870.44962.297
Deferred Income Tax 0003.59300000000-2.203000
Stock Based Compensation 0001.592000000002.218000
Change In Working Capital 151.2894.496-239.011-119.21276.305176.558-267.194-183.37-31.76450.265-80.318-10.299-103.942-345.71-56.992-15.369
Accounts Receivables -60.965193.2362.505-157.466102.38662.72-189.833-112.96354.738-23.668-91.945-122.43917.863000
Inventory 67.611-17.962-116.667-136.05-8.996111.973-105.7-31.627-92.43251.6425.84969.258-73.835-135.896-37.66617.465
Accounts Payables 0-96.221-59.50899.306-30.54341.35922.33-3.444-10.29715.374000000
Other Working Capital 144.643-74.557-65.34174.99813.458-39.494-161.494-151.74360.668-1.377-86.167-79.557-30.107-209.814-19.326-32.834
Other Non Cash Items -40.5579.223-28.04813.284-11.5156.82667.52332.482174.517-1.503-85.863-28.8222.418.512-1.81917.875
Operating Cash Flow 328.669230.39126.616179.868280.603462.52367.56670.828298.057472.152267.604484.767509.665273.447465.587391.286
Investing Activities:
Investments In Property Plant And Equipment -28.244-21.914-36.126-26.199-48.324-56.582-75.288-26.76-38.455-26.662-65.414-247.687-414.703-74.629-161.053-73.336
Acquisitions Net 000-176.3450.823-1.6746.839-14.169-6.015-7.764-13.4895.776-2.457-8.166-12.385-5
Purchases Of Investments -60-1.705-1.999-275-484.755-606.243-180.64-134.202-827.9-283.6-619.25-1,214.679-1,041.679-740.1-722.08
Sales Maturities Of Investments 001.001176.345398.185408.148636.479136.031190.045894.865314.561478.6921,211.6521,033.2731,076.186374.451
Other Investing Activites -1.354-0.583-0.462-6.8193.1442.034-7.1290.5126.2017.53713.580.7572.3028.2546.8945.027
Investing Cash Flow -35.598-22.497-41.366-35.01778.828-132.829-45.342-85.02617.57440.076-34.353-291.712-417.885-82.947169.542-420.938
Financing Activities:
Debt Repayment -30-20-95.508-247.06-94.99598.934-170.251229.0940-500400000
Common Stock Issued 00012.24600000000198000
Common Stock Repurchased 0000-12.24600-1.18100000000
Dividends Paid -109.945-139.93-129.935-109.315-109.945-84.737-149.59-149.59-223.396-246.329-325.154-443.391-476.702-401.232-296.147-124.606
Other Financing Activities -8.724-8.211-7.667-7.144-7.66-7.465-25.1020.8920.110.01800.0091.42000
Financing Cash Flow -148.669-168.141-237.602-351.273-224.8466.732-344.94379.215-223.286-251.311-325.154-443.382122.718-401.232-296.147-124.606
Other Information:
Effect Of Forex Changes On Cash 6.23710.58828.723-25.189-1.337-0.91718.361-21.683-5.0313.208-9.826-17.366-0.065000
Net Change In Cash 150.63950.341-223.629-231.611133.248335.509-304.35843.33487.315274.125-101.729-267.693214.433-210.732338.982-154.258
Cash At End Of Period 532.685382.046331.705555.334786.945653.697318.188622.546579.212491.897217.772319.501587.194372.761583.493244.511